Could Healthsouth Corporation (NYSE:HLS) Change Direction After Less Shorts?

January 21, 2018 - By marketbeat

 Could Healthsouth Corporation (NYSE:HLS) Change Direction After Less Shorts?

Investors sentiment increased to 1.57 in Q3 2017. Its up 0.17, from 1.4 in 2017Q2. It increased, as 30 investors sold Encompass Health Corporation shares while 77 reduced holdings. 44 funds opened positions while 124 raised stakes. 85.46 million shares or 0.59% less from 85.97 million shares in 2017Q2 were reported.
Barrow Hanley Mewhinney & Strauss reported 0.1% in Encompass Health Corporation (NYSE:HLS). Public Employees Retirement Sys Of Ohio, Ohio-based fund reported 95,512 shares. Investment Centers Of America Inc, a North Dakota-based fund reported 99,368 shares. Opus Gp holds 0.71% or 67,635 shares in its portfolio. Envestnet Asset Management reported 0% in Encompass Health Corporation (NYSE:HLS). 1,170 were accumulated by Alphaone Invest Service Ltd Liability Corp. Brinker holds 34,336 shares or 0.07% of its portfolio. Fmr Limited Liability Corporation, Massachusetts-based fund reported 2.06 million shares. State Of Tennessee Treasury Department holds 0.04% or 190,000 shares in its portfolio. Endurant Mngmt Ltd Partnership holds 0.31% or 21,804 shares. Affinity Invest Advsrs Lc stated it has 7,152 shares. Moreover, Benjamin F Edwards And has 0.01% invested in Encompass Health Corporation (NYSE:HLS). Reinhart holds 509,070 shares. Copeland Capital Mgmt Lc, a Pennsylvania-based fund reported 572,702 shares. Tower Rech Cap Lc (Trc) stated it has 11,406 shares or 0.04% of all its holdings.

Since August 3, 2017, it had 0 insider purchases, and 2 insider sales for $1.94 million activity.

The stock of Healthsouth Corporation (NYSE:HLS) registered a decrease of 8.05% in short interest. HLS’s total short interest was 3.13 million shares in January as published by FINRA. Its down 8.05% from 3.40 million shares, reported previously. With 874,000 shares average volume, it will take short sellers 4 days to cover their HLS’s short positions. The short interest to Healthsouth Corporation’s float is 3.94%.

The stock increased 0.20% or $0.1 during the last trading session, reaching $49.41. About 406,041 shares traded. Encompass Health Corporation (NYSE:HLS) has risen 15.04% since January 21, 2017 and is uptrending. It has underperformed by 1.66% the S&P500.

HealthSouth Corporation provides facility and home post-acute healthcare services in the United States. The company has market cap of $4.86 billion. The firm operates through two divisions, Inpatient Rehabilitation, and Home Health and Hospice. It has a 17.87 P/E ratio. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on both an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Encompass Health Corporation (NYSE:HLS) Ratings Coverage

Among 15 analysts covering Healthsouth (NYSE:HLS), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. Healthsouth has $58.0 highest and $40 lowest target. $48.46’s average target is -1.92% below currents $49.41 stock price. Healthsouth had 32 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Friday, July 31 by RBC Capital Markets. The firm has “Buy” rating by Robert W. Baird given on Thursday, October 26. As per Wednesday, January 4, the company rating was initiated by Piper Jaffray. The rating was maintained by Mizuho on Monday, July 10 with “Neutral”. On Wednesday, July 5 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Encompass Health Corporation (NYSE:HLS) has “Neutral” rating given on Wednesday, November 9 by Mizuho. RBC Capital Markets maintained Encompass Health Corporation (NYSE:HLS) on Tuesday, August 1 with “Buy” rating. The stock of Encompass Health Corporation (NYSE:HLS) earned “Outperform” rating by RBC Capital Markets on Monday, February 27. Mizuho maintained it with “Buy” rating and $40 target in Thursday, October 29 report. The rating was maintained by RBC Capital Markets on Monday, November 13 with “Buy”.

More notable recent Encompass Health Corporation (NYSE:HLS) news were published by: Prnewswire.com which released: “HealthSouth Corporation Completes Planned Corporate Name Change To Encompass …” on January 02, 2018, also Seekingalpha.com with their article: “Why HealthSouth Stock Is Rated A ‘Buy With Caution'” published on May 01, 2017, Benzinga.com published: “Credit Suisse: Encompass Health Is The Market Leader In Rehab, Home Health” on January 17, 2018. More interesting news about Encompass Health Corporation (NYSE:HLS) were released by: Streetinsider.com and their article: “Encompass Health Corporation” published on January 08, 2018 as well as Al.com‘s news article titled: “HealthSouth changing its name to Encompass Health Corp.” with publication date: July 10, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: